Cargando…
Comparison of safety and outcomes related to remdesivir treatment among dialysis patients hospitalized with COVID-19
BACKGROUND: Patients with end-stage kidney disease (ESKD) are highly susceptible to coronavirus disease 2019 (COVID-19) infection and its complications. Remdesivir has improved outcomes in COVID-19 patients but its use has been limited among ESKD patients due to insufficient data regarding safety ou...
Autores principales: | Zaki, Kirollos E, Huang, Cheng-Wei, Zhou, Hui, Chung, Joanie, Selevan, David C, Rutkowski, Mark P, Sim, John J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452122/ https://www.ncbi.nlm.nih.gov/pubmed/36320364 http://dx.doi.org/10.1093/ckj/sfac185 |
Ejemplares similares
-
COVID-19 and Survival in Maintenance Dialysis
por: Sim, John J., et al.
Publicado: (2020) -
Efficacy and Safety of Remdesivir in COVID-19 Positive Dialysis Patients
por: Butt, Batool, et al.
Publicado: (2022) -
Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis
por: Geffin, Ryan, et al.
Publicado: (2023) -
Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants
por: Humeniuk, Rita, et al.
Publicado: (2023) -
Safety profile of the antiviral drug remdesivir: An update
por: Fan, Qianqian, et al.
Publicado: (2020)